A Long Term Safety Study of ND0612 Administered as a Continuous SC Infusion in Advanced Parkinson's Disease
Clinical trial NCT02726386 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02726386
- Sponsor
- NeuroDerm Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-04
- Primary completion
- 2019-09-09
- Enrollment
- 214
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.